Skip to main content
SpringerLink
Log in

Intercomparison of S-Factor values calculated in Zubal voxelized phantom for eleven radionuclides commonly used in targeted prostate cancer therapy

  • Scientific Paper
  • Published:
Physical and Engineering Sciences in Medicine Aims and scope Submit manuscript

Abstract

In this study we aimed at comparing various radionuclides ordinarily used in targeted prostate cancer therapy, thereby evaluating S-Factor parameter in the prostate organs as well as in its surrounding healthy tissues, namely the urinary bladder and rectum. InterDosi code version 1.1 was used to estimate S-Factor values in Zubal voxelized phantom for 11 radionuclides, namely 225Ac, 21At, 67Cu, 125I, 131I, 212Pb, 177Lu, 223Ra, 161 Tb, 227Th and 90Y. The prostate organ was considered the source of different ionizing radiation emitted by the radionuclides cited above. The results showed that among all studied alpha-emitting radionuclides, 225 Ac, 223 Ra and 227 Th provide equidistantly the highest self-irradiation S-Factors whereas, 211At provides the lowest cross-irradiation S-Factors. On the other hand, considering only beta-emitting radionuclides, it is shown that 177Lu and 90Y induce respectively lowest and highest cross-absorption S-Factors on the surrounding healthy organs. We conclude that 177Lu and 211At are more adequate for prostate radionuclide therapy because they can relatively prevent surrounding organs from radiation toxicity and at the same time provide sufficient dose to treat the prostate tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10(2):63–89

    Article  CAS  Google Scholar 

  2. Ferlay J EM, Lam F, Colombet M, Mery L, Pineros M, Znaor A, Soerjomataram I, et al. (2019) Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer. https://gco.iarc.fr/today. Accessed 02 Feb 2019.

  3. El Fakiri M, Geis NM, Ayada N, Eder M, Eder A-C (2021) PSMA-targeting radiopharmaceuticals for prostate cancer therapy: recent developments and future perspectives. Cancers 13:3967. https://doi.org/10.3390/cancers13163967

    Article  CAS  Google Scholar 

  4. Czerwińska M, Bilewicz A, Kruszewski M, Wegierek-Ciuk A, Lankoff A (2020) Targeted radionuclide therapy of prostate cancer-from basic research to clinical perspectives. Molecules 25:1743

    Article  Google Scholar 

  5. Ersahin D (2011) Indukala Doddamane and David Cheng. Cancers 3:3838–3855. https://doi.org/10.3390/cancers3043838

    Article  CAS  Google Scholar 

  6. Hao, Guiyang;Mastren, Tara;Silvers, William;Hassan, Gedaa;Öz, Orhan K;Sun, Xiankai. Copper-67 radioimmunotheranostics for simultaneous immunotherapy and immuno-SPEC Scientific Reports 2021, 3622, 11, 1.

  7. Bakkali JEL, Doudouh A, Bardouni TEL, Sahel OA (2021) Monte Carlo calculation of photon specific absorbed fractions in digimouse voxelized phantom using InterDosi code. Radiat Phys Chem 182:109360

    Article  CAS  Google Scholar 

  8. Bakkali JEL, Doudouh A, Bardouni TEL (2021) InterDosi simulations of photon and alpha specific absorbed fractions in zubal voxelized phantom. Appl Radiat Isot 176:109838

    Article  CAS  Google Scholar 

  9. El Bakkali J, Caffrey E, Doudouh A (2021) InterDosi Monte Carlo simulations of photon and electron specific absorbed fractions in a voxel-based crab phantom. Radiat Environ Biophys. https://doi.org/10.1007/s00411-021-00950-6

    Article  Google Scholar 

  10. Agostinelli S, Allison J, Amako K, Apostolakis J, Araujo H, Arce P et al (2003) Geant4 – a simulation toolkit. Nucl Instrum Methods A 506:250–303

    Article  CAS  Google Scholar 

  11. Loeevinger R, Berman M (1968) A schema for absorbed-dose calculations for biologically-distributed radionuclides. J Nucl Med Feb:Suppl 1:9–14. PMID: 5646656

  12. Loevinger R, Berman M. MIRD Pamphlet No. 1, Revised: A Revised Schema for Calculating the Absorbed Dose from Biologically Distributed Radionuclides , March 1976, Society of Nuclear Medicine, NY, 1976

  13. Zubal IG, Harrell CR, Smith EO, Rattner Z, Gindi G, Hoffer PB (1994) Computerized three-dimensional segmented human anatomy. Med Phys 21(2):299–302

    Article  CAS  Google Scholar 

  14. HPC-MARWAN-CNRST computing grid, 2021. https://www.marwan.ma/index.php/services/hpc

  15. Moroccan National Center for Scientific and Technical Research, 2021. https://www.cnrst.ma/

  16. Chauvin M, Borys D, Botta F, Bzowski P, Dabin J, Denis-Bacelar AM, Desbrée A, Falzone N, Lee BQ, Mairani A, Malaroda A, Mathieu G, McKay E, Mora-Ramirez E, Robinson AP, Sarrut D, Struelens L, Gil AV, Bardiès M (2020) Opendose: open-access resource for nuclear medicine dosimetry. J Nucl Med 61(10):1514–1519. https://doi.org/10.2967/jnumed.119.240366

    Article  Google Scholar 

  17. Zubal Phantom Data. https://noodle.med.yale.edu/zubal/data.htm

  18. ICRP (2008) Nuclear decay data for dosimetric calculations. ICRP Publication, Ottawa

    Google Scholar 

  19. Murshed H (2019) Radiation biology fundamentals of radiation oncology. Elsevier, Amsterdam, The Netherlands, pp 57–87

    Book  Google Scholar 

  20. Dayah Chrisman. Cu-67 as a medical isotope, 2016. https://people.nscl.msu.edu/~witek/Classes/PHY802/students2016/Chrisman.pdf

  21. Andersson M, Johansson L, Eckerman K, Mattsson S (2017) IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms. EJNMMI Res 7(1):88

    Article  Google Scholar 

  22. Lehenberger S, Barkhausen C, Cohrs S, Fischer E, Grünberg J, Hohn A, Köster U, Schibli R, Türler A, Zhernosekov K (2011) The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy. Nucl Med Biol 38(6):917–924

    Article  CAS  Google Scholar 

Download references

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Author information

Authors and Affiliations

  1. Nuclear Medicine Department, Military Hospital Mohammed V, Rabat, Morocco

    Jaafar EL Bakkali & Abderrahim Doudouh

  2. Royal School of Military Health Service, Rabat, Morocco

    Jaafar EL Bakkali

  3. Radiations and Nuclear Systems Laboratory, UAE, Faculty of Sciences of Tetuan, Tetuan, Morocco

    Jaafar EL Bakkali, Tarek EL Bardouni, Tarik E. L. Ghalbzouri & Randa Yerrou

  4. Faculty of Medicine and Pharmacy, BioPhysics Laboratory, UM5, Rabat, Morocco

    Abderrahim Doudouh

Authors
  1. Jaafar EL Bakkali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abderrahim Doudouh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tarek EL Bardouni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tarik E. L. Ghalbzouri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Randa Yerrou
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by JELB. The first draft of the manuscript was written by JELB and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jaafar EL Bakkali.

Ethics declarations

Competing interests

The authors have no relevant financial or non-financial interests to disclose.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

EL Bakkali, J., Doudouh, A., EL Bardouni, T. et al. Intercomparison of S-Factor values calculated in Zubal voxelized phantom for eleven radionuclides commonly used in targeted prostate cancer therapy. Phys Eng Sci Med 45, 1251–1256 (2022). https://doi.org/10.1007/s13246-022-01191-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13246-022-01191-7

Keywords

Search

Navigation